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For rapid single-step purification o f recom binant rho­
dopsin, a baculovirus expression  vector was con­
structed containing the bovine opsin  coding sequence 
extended at the S'-end by a short sequence encoding six  
histid ine residues. R ecom binant baculo virus-infected  
Spodoptera frugiperda  cells produce bovine opsin car­
rying a C-terminal h istid ine tag (v-opshis6x). The pres­
ence of th is tag w as confirm ed by im m unoblot analysis. 
Incubation w ith  11-cis-retinal produced a photosensi­
tive pigm ent (v-Rhohis6x) at a level o f 15-20 pmol/106 
cells. The h istid ine tag w as exploited  to purify 
v-Rhohis6x v ia  im m obilized m etal affinity chromatogra­
phy. Optimized im m obilized m etal affinity chromatog­
raphy yielded a binding capacity o f 5:35 nmol of 
v-Rhohis6x per m l of resin  and purification factors up to 
500. B est sam ples w ere at least 85% pure, w ith  an aver- 
age purity o f 70% (A280 nm/A500 nm = 2.5 ± 0.4, n = 7). 
Rem aining contam ination w as largely rem oved upon re­
constitution into lipids, y ield ing rhodopsin proteolipo- 
somes w ith a purity over 95%.
Spectral analysis of v-Rhohis6ac show ed a small but 
significant red sh ift (501 ± 1 nm) com pared to wild type 
rhodopsin (498 ± 1 nm). The pK a of th e Meta I «-» Meta II 
equilibrium in  v-Rhohis6x is dow n-shifted ixom 7.3 to 6.4 
resulting in  a sign ificant sh ift at pH 6.5 tow ard the Meta 
I photointerm ediate. Both effects are reversed upon in ­
creasing the ion ic strength. FT-IR analysis o f the Rho 
Meta II transition  show s that the corresponding struc­
tural changes are identical in  w ild  type and v-Rhohis6x.
Rhodopsin is the major component of the outer segments of 
the vertebrate rod photoreceptor cell. This visual pigment con­
sists of an integral membrane protein to which a chromophore, 
11-cis-retinal, is covalently linked via a protonated Schiff base. 
Rhodopsin triggers the conversion of photon energy (light) into 
a graded membrane potential. The absorption of a photon leads 
to a number of discrete conformational changes in the protein 
moiety of the pigment (sequel of photointermediates -» photo­
cascade), finally resulting in the exposure of G-protein binding 
sites at the cytoplasmic surface of the protein. In the past 
decade, research has focused on analyzing the relationship 
between the structure of the receptor and its functional prop­
erties. Heterologous expression of the protein in combination
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with site-specific mutagenesis has become an attractive way to 
study this relationship. Several expression systems capable of 
in vitro biosynthesis of opsin have been described (1-5). Ex­
pression levels in these systems are usually quite low compared 
to total cell protein (<0.5%) and even to total membrane pro­
tein. For most analyses, recombinant rhodopsin therefore has 
to be extensively purified. Several methods have been de­
scribed for the purification of recombinant rhodopsin (1, 4, 6). 
These methods often have the disadvantage that the obtained 
samples are still contaminated to a various extent with pro­
teins derived from the cells, used for recombinant protein pro­
duction (4, 6). Quite pure preparations can be obtained using 
immunoaffinity chromatography (1). However, this approach is 
expensive (monoclonal antibody, peptides for elution), labori­
ous (antibody production, purification, and coupling), and fairly 
inefficient (low column capacity, recovery only in the order of 
50%). Hence, this procedure is not very suitable for production 
of larger amounts (1-10 mg of purified protein) required for 
structural studies (crystallization, FT-IR spectroscopy,1 NMR 
spectroscopy).
The recombinant baculovirus-based expression system is ari 
excellent system for the production of larger amounts of recom­
binant bovine rhodopsin (6, 7). Thus far, we have used con- 
canavalin A-Sepharose affinity chromatography to purify rho­
dopsin produced in this system (6), which, combined with 
reconstitution into proteoliposomes, yields reasonably pure 
preparations (60-80%). However, it is quite inefficient. Be­
cause of contaminating viral glycoproteins, the column capacity 
for recombinant rhodopsin is small, and a laborious elution 
profile has to be applied. Here we report on an alternative 
approach, using a his Li dine tag engineered onto the C terminus 
of bovine opsin. Histidine tagging for purification of recombi­
nant proteins by means of IMAC has been used for a number of 
proteins both in prokaryotic (8-10) and eukaryotic (11) expres­
sion systems, including recombinant baculovirus (12-14). None 
of these proteins, however, belonged to the superfamily of hep- 
tahelical G-protein-coupled membrane receptors of which rho­
dopsin is a member. Membrane proteins have to be solubilized 
with the help of specific detergents which may impair affinity 
techniques. Hence, we have evaluated IMAC for purification of 
recombinant rhodopsin. Here we will demonstrate that an 
adapted IMAC allows relatively simple, highly efficient single-
1 The abbreviations used are: FT-IR, Fourier transform infrared; 
IMAC, immobilized metal affinity chromatography; v-Rho, wild-type 
regenerated opsin produced in vitro by recombinant baculovirus; 
v-Rhohis0x, C-terminally histidine-tagged regenerated opsin produced 
in vitro by recombinant baculovirus; DoM, dodecyl-^-l-maltoside; 
PIPES, 1,4-piper azinediethanesulfonic acid; MES, 4-morpholineethane- 
sulfonic acid; HEPPS, 4-(2-hydroxyethyl)-l-piperazinepropanesulfonic 
acid; ds, double-stranded; NTA, nitrilotriacetic acid; PAGE, polyacryl­
amide gel electrophoresis.
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step purification of histidine-tagged rhodopsin with an excel­
lent purification factor (>500). The procedure we developed is 
directly applicable to other membrane (receptor) proteins. In­
terestingly, the C-terminally located histidine tag slightly in­
fluences spectral properties (3 nm red-shift) and photocascade 
(downshift of the pKa of the Meta I ** Meta II equilibrium) of 
rhodopsin, however, without perturbing the structural changes 
accompanying the photocascade. The effects are fully reversible 
at higher ionic strength and probably represent unexpected 
electrostatic effects on selected rhodopsin properties.
EXPERIMENTAL PROCEDURES
Materials—Dodecyl“/3-l-maltoside (DoM) and nonyl-j3-l-glucoside 
were prepared as described previously (15). PIPES, HEPPS and MES 
buffers were purchased from Research Organics Inc,, Trolox from Al­
drich, and leupeptin from Sigma. AgCl windows were obtained from 
Fisher Scientific Co.
Construction of the Histidine Tag Transfer Vector (pAcJAC2)—A 
unique BaniBl restriction sequence was engineered in front of the stop 
codon at the 3'-end of the cDNA-encoding bovine opsin (16) using the 
Bio-Had MutaGene kit (Bio-Rad) according to the manufacturer’s in­
structions. This changed the original 3'-end coding sequence from 5'- 
caa gtg gcg cct gcc taa gccc-3' to 5'-caa gtg gat cct gcc taa gccc-3' (Fig. 
IB). Into this Bam lll  site we inserted a short synthetic dsDNA se­
quence with B am lll  overhangs using the two complementary oligonu­
cleotides 5'-gatcctcaccatcaccatcaccactagt-3' and 5'-gatcactagtggtgutggt- 
gatggtgag-3\ The resulting transfer vector, designated pAcJAC2 (Fig.
IA), encodes bovine opsin carrying 6 histidines at the C terminus (Fig,
IB). The sequence was confirmed by dideoxysequencing. We used pAc- 
JAC2 to generate a recombinant baculovirus as described previously (17),
Regeneration and Purification of v-Rhahis({x—Baculovirus propaga­
tion, transfection, isolation of recombinant virus, and Sit) insect cell 
culture are performed as described previously (17, 18), Viral infection 
was performed at a multiplicity of infection of 5. Cells were harvested 3 
days post-infection by centrifugation (4,000 X g, 10 min, 4 °C). Regen­
eration of v-opshisfix into v-Rhohis(}x was accomplished in total cellular 
membrane preparations, Briefly, cell pellets were resuspendcd in buffer 
A (6.5 mM PIPES, 10 mM EDTA, 5 mM dithioerythritol, and 100 ng/ml 
leupeptin, pH 6.5) at 10” cells/ml and lysed upon homogenination (Pot 
ter-Elvehjem-tube), Homogenized cells were centrifuged (30,000 x g 3 20 
min, 4 °C), and the pellet was resuspended in buffer B (20 mM PIPES, 
130 mM NaCl, 10 mM KC1, 3 mM MgCl ,^ 2 mM CaCl2, 0,1 mM EDTA, and 
100 ng/ml leupeptin, pH 6.6). All subsequent manipulations were per­
formed in a nitrogen atmosphere and under dim red light (Schott-Jen a, 
RG 645 cut-off filter). Retina lipids were added in 100-fold molar excess 
over v-opshis(ix, followed by ll-c/s-retinal in a small volume of dimeth- 
ylformamide (10-fold molar excess over v-opshisfix) and solid dodecyl-j8- 
1-maltoside (DoM) to 0.5 mM, Samples were rotated for 2 h at room 
temperature and centrifuged (30,000 x g t 20 min, 4 °C). v-Rhohis(Jx was 
solubilized from the pellet in the same buffer that was used to bind 
v-Rhohis(ix to the Ni2'1' nitrilotriacetic acid agarose resin (NP' -NTA; 
Qiagen). Several buffers were evaluated for the IMAC, Buffer C con­
sisted of 20 mM HEPPS, 0,5 M NaCl, 0,1 mM phenylmethylsulfonyl 
fluoride, 100 ng/ml leupeptin, 1 mM imidazole, 50 ju,m Trolox, and 20 mM 
DoM (pH 8,0), Buffer D was identical with buffer C, except for 10 mM 
imidazole instead of 1 mM. Buffer E was identical with buffer C, oxcept
for buffer and pH: PIPES (pH 6,5) was used instead of HEPPS (8,0). The
regenerated pellets were incubated with these buffers (1 ml/10H cells) 
for 2 h at room temperature to solubilize v-Rhohiafix. Extracts were 
centrifuged (30,000 X g t 20 min, 4 °C) to remove insoluble material, and 
glycerol was added to a concentration of 15% (w/v). The solubilized 
v-Rhohis8x was then applied to the NiB>,'-NTA column at a flow rate of 
1-2 ml/la for 16 h at 4 °C under continuous recycling. This flow rate was 
maintained throughout the entire procedure. Typically, we used a col­
umn volume of 1 ml for the v-RhohisGx extract from 1-2 x 10n infected 
insect cells. Unbound material was eluted from the column with the 
same buffer that was used for loading of the sample except that it was 
supplemented with 15% (w/v) glycerol and 20 mM nonylglycose instead 
of 20 mM DoM (10 column volumes). This was followed by a second rinse 
using the same buffer, but now containing 25 mM imidazole (4 volumes). 
The bound v-Rhohis(Jx was then eluted from the column using the same 
buffer (C, D, or E) supplemented with 100 mM imidazole and containing 
20 mM nonylglucose instead of DoM and 130 mM instead of 500 mM 
NaCl (6 volumes).
Reconstitution of Purified v-RhohisCtX into Retina Lipids—Retina lip­
ids were extracted from illuminated bovine retinae using standard proce­
dures (19), The lipids were stored at -8 0  °C in the dichloromethane/ 
methanol extract. Their concentration was determined by a modified 
Fiske-Subbarow phosphate assay (20). The aliquot required for reconsti­
tution is dried with argon gas, dissolved in a small volume of methanol, 
and then diluted with buffer B containing 20 mM nonylglucose.
Purified v~Rhohisr>x was concentrated to 3—10 nmol/ml on an Omega 
30K filter (Filtron, Northborough, MA) and mixed with 1 volume of 
retina lipid extract (100-fold molar excess). This mixture was layered on 
top of a sucrose step gradient (10%, 20%, and 45% (w/w) in 3 X diluted 
buffer B) and spun overnight (100,000 X g } >16 h, 4 °C). Reconstituted 
v-Rhohis(ix was collected from the 20% and/or 45% interface. Collected 
proteoliposomes were either diluted with the required buffer, and used 
for analysis, or with distilled water, pelleted (80,000 x ^ , 1 h, 4 °C), and 
stored at -8 0  °C until further use.
Immunoblot Analysis—Proteins were separated on a 12.5% SDS- 
polyaery 1 amide gel (21), transferred to nitrocellulose (Schleicher and 
Schull BA85, pore size 85), and probed with monoclonal or polyclonal 
antibodies (17). The anti-opsin antibodies Rho-lD4 (monoclonal) and 
CERNJS858 (polyclonal) have been described before (22, 23) and were 
used in 1:1000 dilution. The anti-histidine tag antiserum was obtained 
from Cappel, Organon Teknika N.V., Turnhout. Belgium and was also 
used 1:1000,
UV/Vis Spectroscopy and Photolysis—UV/Vis spectroscopy to deter­
mine absorbance band shape and A,mix was routinely performed at pH 
6.5 in buffer B supplemented with 20 mM DoM using a Perkin-Elmor 
A15 recording spectrophotometer. Detergent was added to prevent 
light-scattering artifacts. The spectrum of detergent-solubilized sam­
ples was recorded, after addition of 1 m hydroxylamine to 50 mM, before 
and after illumination (5 min, 300-watt light bulb, KGl. heat filter, 
Schott, Mainz, FRG). For accurate determination of the Anmx, difference 
spectra were used (illuminated spectrum subtracted from the “dark’ 
one).
The late photointermcdiates Meta I, Meta II, and Meta III were 
studied at 10 °C in proteoliposomes of v-Rhohis<}x, using isotonic solu­
tions buffered with 20 mM PIPES (pH 6.5-7.0), 20 mM MES (pH 5.5- 
6.0), or 20 mM HEPPS (pH 7.5-9,5) (24). The photocascade was trig­
gered by illumination for 15 s (Schott 00530  cut-off filter), and spectra 
were recorded every 3 minutes, After 30 min, hydroxylamine was added 
to 50 mM to convert all photoproducts into opsin and rolinaloxime, and 
remaining rhodopsin was bleached away by a 5-min illumination.
Fourier Transform Infrared (FT-IR) Difference. Spectroscopy—FT-IR 
spectra of the rhodopsin -* Meta II transition wore recorded in principle 
as described previously (25, 26). Briefly, 1 nmol samples were deposited 
on AgCl windows by isopotential spin-drying (27). The resulting films 
were hydrated with 3 /xl of MES buffer (pH 5.5), covered with another 
AgCl window, sealed with Teflon tape, and mounted into a variable 
temperature cell (Specac P/N215G0, Kent, UK). FT-IR spectra were 
recorded on a Mattson Cygnus 100 spectrometer (Madison, WI) 
equipped with a liquid nitrogen-cooled, narrow band MCT detector. 
Sample hydration was monitored by the ratio between the peak absorb­
ance near 3400 cm" 1 (OH stretching mode of water) and near 2900 cm 1 
(CH stretching mode of protein and lipids). Rhodopsin —> Meta II 
difference spectra were recorded at 10 °C. Spectra were taken at 8 cm 1 
resolution in 5-min blocks before and after illumination at (1280 scans/ 
spectrum). Each sample was illuminated for 30 s in the spectrometer 
under computer control using a 12-V 20-watt halogen lamp equipped 
with Schott KGl and GG530 cut-off filters. Difference spectra were 
computed by subtracting spectra before illumination from spectra taken 
after illumination, using the EXPERT-IR software (Mattson),
RESULTS
Construction o f  the H istid ine Tag Transfer Vector pAcJAC2  
and Generation of Recom binant Virus—In order to introduce a 
tag consisting of six histidines at the C terminus of bovine 
opsin, the transfer vector pAcJAC2 was constructed (Fig. 1A). 
pAcJAC2 is derived from the baculovirus transfer vector 
pAcDZl (28), A short synthetic sequence encoding a histidine 
tag followed by a stop codon was introduced at the C terminus 
using two complementary oligonucleotides (Fig. IB). As a re­
sult, the two alanine residues at the C terminus of opsin (Ala- 
346 and Ala-348) were substituted by an aspartic acid and the 
first histidine residue, respectively (Fig. IB), These substitu­
tions concern residues, which are not highly conserved. Also, 
the aspartic acid residue introduced should partly counterbal­
ance the additional charge carried by the histidine tag.
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A Sphl 4645
Spel 5050 
BamHI 5030
EcoRV 4000 EcoRl 5330
SstI 56Q0
Sphl 2135
Xnol1901
BstEll 923
EcoRV 7340
EcoRI8400 
Pstl 8450
Xhol 8820 
Xbal 8880 
Psti 8900
B
Bovin« op« in c-tarminal s«qu«nc«
1140
GAC GAC GAG GCC TCC ACC ACC GTC TCC AAG ACA GAG ACC AGC CAA GTG GCG CCT GCC TAA GCCCCAGGGACTCCGTGGC 
Asp Asp Glu Ala Ser Thr Thr Val ser Lys Thr Glu Thr Ser Gin Val Ala Pro Ala
340 348
Bovina opsin containing a Hi»tidin«-tag at the C-t«iminu*
1140
GAC GAC GAG GCC TCC ACC ACC GTC TCC AAG ACA GAG ACC AGC CAA GTG OAT CCT CAC CAT CAC CAT CAC CAT TAG TGATC 
Asp Asp Glu Ala Ser Thr Thr Val Sar Lys Thr Glu Thr Sar Gin Val Asp Pro His His His His His His
340 348
F ig . 1. Cloning an d  C -term inal m odification  o f v-opshisc*. A, schematic diagram of the transfer vector pAcJAC2. This vector was used to 
produce recombinant baculovirus AcNPV/opshis expressing bovine opsin carrying 6 histidine residues at the C terminus. The plasmid contains the 
cDNA encoding bovine opsin (•—-). Opsin expression is controlled by the polyhedrin promoter (Ppolh). The Drosophila hsp70 promoter {PhH})70) and 
the ZacZ marker gene, used to identify' recombinant virus, are identical with vector pAcDZl (28). Cleavage sites for several restriction enzymes are 
denoted. B, the amino acid and DNA sequences of bovine opsin and the histidine-tagged opsin (designated v-opshisGx) encoded by pAcJAC2, are 
displayed.
In pAcJAC2, opsin biosynthesis is controlled by the poly­
hedrin promoter while the small heat shock promoter of hsp70, 
drives the biosynthesis of /3-galactosidase, which functions as a 
reporter enzyme (17, 28).
Expression of v-opshis6x using Recombinant Virus AcNPV/ 
ops his—Protein samples derived from recombinant virus-in- 
fected Sf9 cells were analyzed by immunoblot, using a poly­
clonal antiserum elicited against bovine opsin (Fig. 2A). Wild- 
type virus-infected Sf9 cells are used as a negative control, and 
native bovine opsin and wild-type v-ops as positive controls 
(Pig. 2A, lanes 1,2, and 4). The presence of the histidine tag in 
v-opshis6x was confirmed by the following observations: 1) only 
v-opshis6x is recognized by the histidine tag antibody (see be­
low), 2) the apparent molecular mass of v-opshis6x is larger (by 
about 2 kDa) than that of native opsin and v-ops (Fig. 2A, lane
3 versus lanes 2 and 4), 3) v-opshis6x does not react with the 
monoclonal antibody 1D4 (Fig. 2B, lane 1 versus 2), since the 
C-terminal histidine tag extension eliminates the epitope for 
this antibody (29).
Hence, recombinant virus AcNPV/opshis directs expression 
of a fully intact histidine-tagged v-ops. The expression level 
varies between 20 and 30 pmol/106 cells, which is comparable 
to wild-type v-ops (6).
Regeneration and Purification ofv-Rhohis6x—To convert ex­
pressed v-opshis6x into v-Rhohis6x, we incubated total mem­
branes, harvested at 3 days post-infection from infected Sfë 
cells, with 11-cis-retinal. Spectral analysis of regenerated sam­
ples showed that this resulted in 18 ± 2 pmol of v-Rhohis6x per 
106 cells (n = 7). For purification by IMA.C, regenerated sam­
ples were solubilized using DoM as a detergent and loaded onto
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Fig. 2. Immunoblot analysis of v-opshis«* expression. Blots 
were screened with anti-rhodopsin antibodies: the polyclonal antiser­
ums CERNJS858 (A) and the monoclonal, C-terminally directed Rho- 
1D4 (B)} respectively. The lanes in A contain; mock-infected Si9 cells 
{lane 1), native bovine opsin (lane 2 ), and SfB cells expressing v-opshi8(}x 
(lane 3) or v-ops (lane 4). B, native bovine opsin (lane 2) and v-opshis0jc 
(lane 1). v-opshis0x clearly runs at higher apparent molecular mass than 
wild-type and is recognized by CERNJS858, but, in contrast to wild- 
type, not by 1D4.
a Ni2'h-NTA agai'ose column. This column appeared to bind 
v-Rhohis6x with high capacity. Proteins, which have natural 
affinity for metal ions are bound as well. A variety of washing 
and elution conditions have been tested to remove this contam­
ination as much as possible without sacrificing binding capac­
ity of the column and recovery of v~Rhohis6x. Eluted fractions 
were analyzed by SDS-PAGE (protein pattern), immunoblot- 
ting (anti-rhodopsin CERNJS858 antiserum), and by UV/Vis 
spectroscopy (Ar>00 to detect and quantify v-Rhohis(Jx; ratio A2H0/ 
A500 as a purity indicator). Typical results are presented in Fig. 
3 and Table I. Lane 1 in Fig. 3, A, 23, and C, presents the total 
extract of Sf9 membranes after regeneration. Only by immu­
noblot analysis can glycosylated v-opshis(JX be identified (ar­
row) together with a minor amount of unglycosylated species 
{arrowhead). The nonbound, flow-through fraction shows a 
very similar protein pattern {lane 2 ), except that most 
v-Rhohisfix has bound, since only minimal amounts of the gly­
cosylated form are detected in this fraction. Additional wash­
ings with extraction buffer (buffer C) elute a complex protein 
population (Fig. 3, lanes 3 and 4), probably representing aspe- 
cifically or very weakly bound proteins. The nonglycosylated 
v-opshis6x is already strongly present in these fractions (Fig, 3, 
B and C, lanes 2 -4 , arrowhead) and apparently is not very well 
retained by the column. Protein contamination, weakly inter­
acting with the column, could be eluted by raising the imidaz­
ole concentration to 26 mM (Fig, 3, lane 5). Under these condi­
tions, a minor amount of v-Rhohisflx was eluted. Most of the 
specifically bound v-Rhohis0x, however, only was eluted upon 
raising the imidazole concentration to 100 mM (Fig. 3, lane 6). 
This fraction also contains a minor amount of nonglycosylated 
species and is still contaminated by several other minor bands 
(Fig. 3A, lane 6, open arrowheads).
The amount of nonglycosylated v-opshis(>x in the DoM extract 
and column fractions varied between different experiments, 
but it was always present at immunodetectable levels (data not 
shown). In addition, immunoblots showed the presence of a 
third opsin species (Fig. 3£, lanes 1-4) which on SDS-PAGE 
gels migrated between the glycosylated and nonglycosylated 
v-opshis6x. This species did not react with the anti-histidine tag 
antibody (Fig. 3C, lanes 1-4), We were unable to detect this 
band in the final purified v-Rhohis^ fraction (Fig. SB, lane 6‘).
An overview of IMAC results obtained under two conditions, 
as determined by spectroscopic analysis, is given in Table I. 
Nearly complete binding of v-Rhohis6x to the Ni2‘* -NTA agar­
ose was attained. At pH 8.0 (buffer C), a pH at which IMAC is
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Fiii, 3. Typical p urification  profile o f v-R hohis0x u sin g  IMAC,
Fractions were analyzed by SDS-PAGE (A, Cooniassio blue staining) 
and immunoblot (B and C). Immunoblots were screened with the poly­
clonal anti-rhodopsin antibody OERNJS858 (B) and the anti-histidine 
tag antibody (C). Lane 1 represents the Sf9-ccll membrane extract 
loaded onto the Ni^'-NTA-agarosc column. The nonbound fraction is 
shown in lane 2. Lanes 3  and 4 represent early fractions eluted upon 
washing with buffer C, whereas lane 5 contains the proteins that eluted 
from the column after supplementing butter C with 25 mM imidazole. 
The strongly bound fraction, eluted from the column using buffer C 
supplemented with 100 mM imidazole, is shown in la m  6. Lanes 7 and 
8 in A represent purified, reconstituted native bovine rhodopsin (lane 7) 
and v-Rhohi9(Jx (lane 8). Position of glycosylated (large arrow) and 
nonglycosylated (small, filled arrowhead) v-Rhohisflxl as well as the 
intermediate do-liistidine-tagged form (large arrowhead) and some mi­
nor contaminants in the purified fraction (small open arrowheads) are 
indicated. The immunopositive bands (B and C) and the Goomasaie- 
positivo band (A, lane S) around 67 kDa represent a dimer of v-Rhohistt)e.
usually performed, an average recovery of 84% was achieved 
with a purification factor of at least 450. An attempt to reduce 
contamination by weakly binding proteins, by applying the 
membrane extract in the presence of a higher imidazole con­
centration (10 mM; buffer D), resulted in a much higher loss of 
v-Rhohis0x and in fact lowered the purification factor (not 
shown). Finally, the performance of the procedure we devel­
oped at pH 8.0, was evaluated at pH 6.5, since rhodopsin and 
most of its mutants are thermally much more stable at the
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T able I
General characteristics of v-Rhohisffx purification by IMAC as
determined by UVjVis spectroscopy
Values given are mean ± S.D. of three experiments. The percentage 
solubilization is related to the amount solubilized under standard con­
ditions (6), which was taken as the 100% value.
Condition
Buffer C Buffer E
Solubization (%) 100 ± 20 100 ± 8
Nonbound {%) 8 ± 5 5 ± 6
Recovery (%) 84 ± 4 80 ± 5
2.7 ± 0.4 2.4 ±0.4
latter pH. This actually improved the purification factor to at 
least 500, without significant reduction in recovery (Table I, 
buffer E). At pH 6.5, best v-Rhohis6x samples had a purity of 
80-85% (A280/A500 ratio of 2.0—2.1), and the average purity of 
combined fractions was 70-75%. The maximal capacity of the 
Ni2_h-NTA agarose column for v-Rhohis6x has not been deter­
mined exactly but is at least 35 nmol/ml bed volume. The 
efficiency of this IMAC procedure is spectrally illustrated in 
Fig. 4A. Curve 1 represents the total membrane extract applied 
to the column, while curve 2 presents the spectrum of the 
combined purified v-RhohisGx fractions.
The contamination in the v-Rhohis6x fraction obtained after 
IMAC resides in several minor bands. These are largely re­
moved upon subsequent reconstitution of v-Rhohis6x into ret­
ina lipid proteoliposomes, which represent a more native-like 
environment, we routinely use to analyze functional properties 
of recombinant rhodopsin (6). To simplify reconstitution, the 
detergent used during regeneration (DoM) is exchanged during 
IMAC for nonylglucose, which is more easily exchanged for 
phospholipids (30). The resulting v-Rhohis6x proteoliposomes 
contain at least 95% rhodopsin on a protein base and are 
suitable for all functional analyses (Fig. 3A, lane 8)
Spectral Pi'opei'ties and Photocascade of v-Rhohis6x—Curve 2 
in Fig, 4A is a typical absorbance spectrum of the combined 
v-RhohisSx fractions obtained after IMAC purification. Illumi­
nation of v-Rhohis6x “bleaches” the main absorbance band at 
500 nm, and we used difference spectra to calculate the Amax 
more accurately. Unexpectedly, the absorbance band of 
v-Rhohis6x turns out to be slightly red-shifted (Amax = 501 ± 1 
nm, n -  7) relative to wild-type (Amax = 498 ± 1 nm) (Fig. 4B). 
This slight but significant red shift has been observed in all 
samples produced so far, both before and after IMAC purifica­
tion. The shift is independent of the presence of 10 mM Ni2* ions 
(complexed histidine tag) or 10 mM EDTA (free histidine tag).
Analysis of the later part of the photocascade of reconstituted 
v-Rhohis6x presents another subtle effect of histidine tagging: 
at pH 6.5, the Meta I «■> Meta II equilibrium is clearly shifted 
toward Meta I (Fig. 5JB) in comparison to wild-type rhodopsin 
(Fig. 5A). At pH 5,5, v-Rhohis6x again behaves similar to wild- 
type (Fig. 5C: little Meta I formed, normal formation of Meta 
III). Again, this effect is not influenced by excess Ni2+ ions or 
complexing agent (EDTA). Analysis over a larger pH range, in 
fact, demonstrates that the pKa of the Meta Meta II equi­
librium is down-shifted about 1 pH unit from 7.3 in wild-type to 
6.4 (Fig. 6).
Hence, we reasoned that these subtle changes in v-Rhohis 
properties might be due to the additional surface charge intro­
duced by the histidine tag. Increasing the ionic strength by 
addition of KC1 up to 1 m concentration indeed reverted Amax 
and photocascade of v-Rhohis6x to wild-type behavior (Table II).
Structural Analysis of the Rho —> Meta I I  Transition by 
FT-IR Spectroscopy—FT-IR difference spectroscopy provides 
detailed structural information on the transitions in the rho­
dopsin photocascade (e.g. Refs. 25-27, 31, and 32). We have
used this approach to investigate whether histidine tagging 
would also exert influence on the conformational changes ac­
companying Meta II formation. Comparison of the FT-IR dif­
ference spectra for the rhodopsin to Meta II transition in native 
rhodopsin and v-Rhohis6x shows that these spectra are highly 
similar (Fig. 7). All major bands characteristic of the formation 
of Meta II (numbers in cm“1) are present in v-Rhohis6x as well 
and within experimental error (±2 cm“1) at the same fre­
quency as wild-type. Hence, the histidine tag does not detect- 
ably influence the conformational changes accompanying pho­
to excitation of rhodopsin.
DISCUSSION
Purification of Recombinant Membrane Receptors—G-pro- 
tein-coupled membrane receptor proteins have been expressed 
in all common in vitro expression systems (mammalian cell 
lines, insect cell lines, yeast, Escherichia coli)} but the levels of 
expression are always low (<0.5% of cellular protein). Hence, 
for more elaborate functional studies as well as for structural 
studies, a very efficient purification procedure is needed. The 
most selective and frequently used approach is to exploit re­
ceptor affinity for an (ant)agonist or a monoclonal antibody. For 
instance, the most popular way to purify recombinant rho- 
dopsins is by immunoaffinity chromatography over immobi­
lized 1D4 (1, 33).
However, this approach has several disadvantages: it suffers 
from rather low recoveries (^50% in our hands), low column 
capacity (1-2 nmol/ml bed volume), and expensive exploitation 
(monoclonal antibodies, peptide for elution). It is therefore not 
very suitable to purify larger amounts of recombinant protein. 
As an alternative, we adapted lectin affinity chromatography 
over concanavalin A-Sepharose to the recombinant baculovirus 
system (6, 17). This technique gives good recoveries (3:80%) 
and is fairly inexpensive, but due to the large contamination 
with viral glycoproteins, a complex elution profile has to be 
applied and the column capacity for rhodopsin binding is low 
(approximately 1 nmol/ml bed volume). As a consequence, it 
only affords rather low purification factors (50-100) and is 
quite laborious in the case of larger batches. We therefore 
searched for other alternatives and IMAC in combination with 
histidine tagging looked like a good candidate (8-13).
IMAC Purification of Histidine-tagged Rhodopsin—We se­
lected the C-terminal of rhodopsin as a suitable site for append­
ing a 6x histidine tag since 1) this site allows immuno affinity 
purification and therefore should be well accessible and 2) 
C-terminal extension does not significantly influence func­
tional properties of the protein (33, 34).2
Recombinant histidine-tagged bovine opsin could be success­
fully, functionally expressed in the recombinant baculovirus/ 
insect cell expression system. Regeneration with 11-cis-retinal 
resulted in a pigment (v-Rhohis6x) that could be purified almost 
to homogeneity in a single step using IMAC under optimized 
conditions. This purification procedure is rapid, fairly inexpen­
sive, yields good recoveries (£=80%) with an excellent purifica­
tion factor (^500), and can handle, thanks to the high column 
capacity (2:35 nmol/ml bed volume), relatively large batches of 
rhodopsin. Interestingly, the histidine tag at the C terminus 
was found to have a subtle influence on the spectral and pho- 
tolytic properties of this visual pigment, but these effects could 
be reversed by increasing the ionic strength.
The presence of the histidine tag at the C terminus of bovine 
opsin was first confirmed by immunoblot analysis. The modi­
fied C terminus was no longer recognized by the monoclonal 
antibody Rho-lD4 (29), and v-opshis6x was clearly identified by 
a polyclonal antibody elicited against a hexahistidine peptide.
2 G. L. J. De Caluwé and W. J. De Grip, unpublished data.
Histidine Tagging of Recombinant Bovine Rhodopsin 11227
<DOaCO
■B
gJD
<
.2
.1
400 500
Wavelength (nm) Wavelength (nm)
Fig. 4. Spectral analysis of the IMAC purification of h istid ine-tagged rhodopsin . A } UV/Vis absorbance spectrum of the regenerated 
DoM extract that was applied to the Ni2+-NTA agarose column (curve 1)\ typical absorbance spectrum of v-Rhohis0x after purification by IMAC 
(curve 2). The two spectra were normalized to the absorbance at 278 nm, the maximum of the protein absorbance band. ¿3, difference spectra 
(illuminated subtracted from dark) of purified v-Rho (curve 1) and v-Rhohis0x (curve 2 ). Spectra were recorded in the presence of 50 mM 
hydroxylamine.
In addition, the apparent molecular mass of v-opshis6]C on the 
immunoblots has increased relative to v-ops. Our histidine tag 
should increase the molecular mass by approximately 0.7 kDa. 
The observed shift of the apparent molecular mass, seen on the 
immunoblots, is at least 2 kDa, however. This might reflect a 
direct or indirect (SDS binding) effect due to the additional 
charge introduced by the histidine residues, which would 
change the migration behavior on the gel. Such a large effect 
has not been reported before but it might be more pronounced 
in the case of membrane proteins, which by themselves usually 
show aberrant behavior in SDS-PAGE.
Ultimate proof for the presence of the histidine tag in 
v-opshis6x of course lies in the successful application of IMAC 
using Ni2'1“ chelation. With this technique we could combine a 
high column capacity with high purification factors and good 
recoveries. The A280/A5{)() ratio indicates that, under optimized 
conditions, the combined purified fractions on average contain 
at least 70% v-Rhohis6x. However, peak column fractions have 
been obtained in which this was as high as 80-85%. Immuno­
blot analysis shows that the purified v-Rhohis6x samples con­
tain some nonglycosylated v-opshis6x. Lack of glycosylation 
was reported to reflect impaired protein folding and loss of 
regeneration capacity (17, 35). Therefore, one of the contami­
nants present in the v-Rhohis6x samples is v-opshisflx. Protein 
staining of PAGE gels reveals in addition to non glycosylated 
v-opshis6x two minor bands at ca 25-30 kDa, Hence, these 
three proteins are the major contaminants after IMAC. Upon 
subsequent reconstitution into proteoliposomes, this remaining 
contamination is also largely removed. In the case of opsin this 
is due to its relative low stability in detergents and tendency to 
aggregate, which impairs correct reconstitution into a lipid 
matrix. Indeed, absolute FT-IR absorption spectra, where the 
amide I (1620-1690 cm*“1) and amide II (1530-1560 cm"1) 
bands are extremely sensitive to protein secondary structure 
(36), do not suggest the presence of any (partially) misfolded 
opsin,3 while this was clearly observed for the mutants E134D 
and E134R (31).
In addition to glycosylated and nonglycosylated (rhod)opsin, 
a third anti-opsin immunoreactive band was detected, primar­
ily in the IMAC wash fractions. The latter band migrates
3 J. J. M. Janssen, P. H. M. Bovee-Geurts, M. Merkx, and W. J. 
DeGrip, unpublished observations.
between the first two bands and is not recognized by the anti­
histidine tag antibodies. This opsin species is only formed in 
minor amounts (<5% of total), and, presently, it is not clear 
where it derives from. It could be due to chemical cleavage of 
the histidine tag on the column, e.g. in the Ni2 ‘-complexed 
from, or derive from endogenous carboxy peptidase activity pres­
ent in the Sf9 cells. Both reactions might remove up to the 
entire tag, which would explain why this species has no or only 
low affinity for the Ni2'* -NTA agarose and is not recognized by 
the anti-histidine tag antibodies. Thus far, no one has de­
scribed a similar observation or any carboxypeptidase activity 
in Sf9 cells although a C-terminal histidine-tagged protein has 
been purified from this expression system before (13). However, 
we only did observe this (partial) removal of the histidine tag 
from v-Rhohisflx because of the relative large difference in 
apparent molecular mass between v-Rho and v-Rhohis6x and 
the availability of the anti-histidine tag antiserum. In the 
earlier reports, no large difference in molecular mass between 
the native and histidine-tagged proteins was observed, and no 
antiserum against the histidine tag was available. On the other 
hand, carboxypeptidase activity has been previously put to 
good use to remove a polyhistidine peptide fused to dihydrofo­
late reductase after purification from expression in E . coli (9). 
Hence, if cleavage of the histidine tag does become a serious 
problem for certain proteins, it is recommendable either to in­
clude carboxypeptidase inhibitors during extraction and purifi­
cation or to protect the histidine tag with a C-terminal proline 
residue or to insert/append it elsewhere into the protein.
Functional Properties of v-RhohisGx—The expressed 
v-opshisBx smoothly recombines with the chromophore, 1 1 -cts- 
retinal, into a functional photopigment. However, unexpect­
edly, the absorbance spectrum of v-Rhohis(ix shows a small but 
significant red shift (Amnx — 501 nm) and the pKa of the Meta
I Meta II equilibrium is shifted down* These effects are not 
due to the presence of a Ni2+-histidine tag complex, since they 
do not depend on the presence of Ni2'f ions and are not reversed 
by addition of an excess of the complexing agent EDTA. How­
ever, both shifts are fully reversed by the addition of 1 m KC1. 
Hence, presently we think that these subtle functional effects 
result from the additional surface charge introduced by the 
histidine tag at the cytoplasmic surface of v-Rhohis6x. This 
could lead to an alkaline shift in the surface pH, which could 
explain the apparent downshift of the p Kn of the Meta I Meta
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Fig. 5. Spectral analysis of la te photointerm ediates (Meta I, 
Meta II, and Meta III). v-Rho (A) and v-RhohisSx (B and C) were 
reconstituted in retina lipid proteoliposomes, Spectra shown in A andB 
were recorded at pH 6.5. The spectrum shown in C was obtained at pH 
5.5. Upon illumination, the dark spectrum (spectrum 1) is converted 
into an equilibrium mixture of Meta II (380 nm) and Meta I (480 nm) 
(spectrum 2), which slowly decays under formation of Meta III (level after 
30 min; spectrum 3). Addition of hydroxylamine then converts all photo­
products into opsin, retinaloxime, and remaining rhodopsin (spectrum 4). 
A final illumination bleaches away remaining rhodopsin (spectrum 5).
II equilibrium. In addition, electrostatic effects (either local or 
more general like an increase in the protein dipole) could be 
involved. Both effects would indeed be suppressed by an in­
crease in ionic strength. It would be quite exciting if electro­
static effects could at least partially be responsible for the 
observed phenomena, since to our knowledge such “long range 
influence” has not been documented yet. We are presently 
investigating this in more detail by mapping bulk-pH depend­
ence, measuring surface pH, establishing reversal by removal 
of the histidine tag, and insertion of the histidine tag in other
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F ig . 6. pH dependence of the Meta I «-> Meta II equilibrium  of 
v-Rho and v-Rhohis0x. Percentage of Meta I present upon illumina­
tion of reconstituted v-Rho (open circles) or v-Rhohis6x (closed circles) 
was measured in dependence of pH. Data points were fitted with the 
Henderson-Hasselbach equation for a single group titration, yielding a 
pKa of 7.3 for v-Rho and 6.4 for v~RhohisGx.
T able II
Reversal of histidine tag effects by an increase in ionic strength
The Amnx was determined from difference spectra (cf Fig. 4B), The 
percentage of Meta I remaining in the Meta I «-> Meta II photoequilib­
rium at pH 6.5 is calculated from the absorbance difference at 480 nm 
(spectrum 2 minus 4 in Fig. 5). Mean ± S.D. of n determinations is 
given. This increase in ionic strength does not significantly affect this 
proportion in bovine rhodopsin.
KC1 Meta I remaining
v-Rhohisfìx 0.1 501 ± 1 (n 44 ± 5 (n = 4)
1.1 499 ± 1 (n = 2) 15 ± 3 (n « 2)
v-Rho 0.1 498 ± 1 (n ss 15) 19 ± 4 (n — 5)
positions.
In order to establish whether the effect of the histidine tag 
would also penetrate at the structural level, FT-IR analysis 
was performed. The band shape of the amide I band indicates 
a very similar secondary structure composition for rhodopsin 
and v-Rhohis6xJ and the FT-IR difference spectra correspond­
ing to the rhodopsin to Meta II transition are also highly 
similar. All characteristic bands of this transition (at 970,1562, 
1643, 1686, 1712, 1728, 1750, and 1768 cm“1; the latter two of 
which have recently been assigned to the C =0 stretching mode 
of aspartic acid 83 (31, 32)) are also present in the difference 
spectrum obtained with v-Rhohis6x, Hence, according to anal­
ysis by FT-IR, no significant differences exist in the structural 
alterations accompanying receptor activation in rhodopsin or 
v-Rhohis6x.
Conclusion—The use of IMAC in combination with histidine 
tagging has considerably improved and simplified the purifica­
tion of recombinant rhodopsin. This will now permit us to 
further scale up the cell culture volume and recombinant pro­
tein production, which thereby will yield sufficient protein for 
more detailed structural studies, requiring modified protein 
(FT-IR, NMR, crystallization).
The adaptations we have introduced in the IMAC (use and 
exchange of detergents, lower pH, stepwise imidazole elution) 
should make it applicable for membrane proteins in general. It 
cannot be foreseen whether the subtle influence of the histidine
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Fig. 7. FT-IR analysis of photoexci­
ta tion . FT-IR difference spectra are pre­
sented corresponding to the Rho -» Meta 
II transition of reconstituted native bo­
vine rhodopsin (upper spectt'um) or 
v-Rhohis6x (lower spectrum). Both transi­
tions were recorded at 10 °C and pH 5,5 at 
isotonic ionic strength. Bands character­
istic for Meta II formation are indicated 
by wavenumber (cm“1),
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tag on functional properties, observed for rhodopsin, would also 
always emerge in other membrane receptors. However, the 
histidine tag apparently need not influence the conformational 
changes accompanying receptor activation, and any functional 
effects can easily be suppressed by an increase in ionic strength 
or, if properly placed, be abolished by its proteolytic removal.
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